NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles

FDA DecisionPreservative-Free KetaminePositive

AI Analysis

Summary

NRx Pharmaceuticals is nearing an FDA decision on its preservative-free ketamine formulation after successfully clearing review hurdles. The company is awaiting regulatory approval for the drug candidate.

Outcome Details

FDA review cleared hurdles, decision pending

Importance:7/10

Sentiment:

0.60

FDAPDUFAketaminepreservative-freeregulatory

Related Companies

$NRXP

Read the original article

Published by yahoo_finance on August 10, 2026 2:04 PM

Read Original